Smilek, D E; Gautam, A M; Pearson, C et al. (1992) EAE: a model for immune intervention with synthetic peptides. Int Rev Immunol 9:223-30
|
Acha-Orbea, H; McDevitt, H O (1990) The role of class II molecules in development of insulin-dependent diabetes mellitus in mice, rats and humans. Curr Top Microbiol Immunol 156:103-19
|
Wraith, D C; Smilek, D E; Mitchell, D J et al. (1990) T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides. Int Rev Immunol 6:37-47
|
Wraith, D C; Smilek, D E; Mitchell, D J et al. (1989) Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247-55
|
Jacob, C O; Holoshitz, J; Van der Meide, P et al. (1989) Heterogeneous effects of IFN-gamma in adjuvant arthritis. J Immunol 142:1500-5
|
Acha-Orbea, H; Steinman, L; McDevitt, H O (1989) T cell receptors in murine autoimmune diseases. Annu Rev Immunol 7:371-405
|
Davis, C B; Mitchell, D J; Wraith, D C et al. (1989) Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. J Immunol 143:2083-93
|
Davis, C B; Buerstedde, J M; McKean, D J et al. (1989) The role of polymorphic I-Ak beta chain residues in presentation of a peptide from myelin basic protein. J Exp Med 169:2239-44
|
Heber-Katz, E; Acha-Orbea, H (1989) The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today 10:164-9
|
Chao, N J; Timmerman, L; McDevitt, H O et al. (1989) Molecular characterization of MHC class II antigens (beta 1 domain) in the BB diabetes-prone and -resistant rat. Immunogenetics 29:231-4
|
Showing the most recent 10 out of 19 publications